Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Terumasa Hashimoto is active.

Publication


Featured researches published by Terumasa Hashimoto.


Journal of Ocular Pharmacology and Therapeutics | 2003

Effects of Nonsteroidal Anti-Inflammatory Drugs on Experimental Allergic Conjunctivitis in Guinea Pigs

Terumasa Hashimoto; Atsushi Igarashi; Futoshi Hoshina; Mie Yamada; Yoshihiro Toyoda; Yoshitada Notsu; Shigekatsu Kohno

The effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on experimental allergic conjunctivitis, induced by ocular challenge with antigen in actively sensitized guinea pigs, were investigated. NSAIDs reduced the increase in prostaglandin D2 (PGD2) and E2 (PGE2) in the ocular lavage fluid. The inhibition of NSAIDs to these increases was approximately 90%-95%. NSAIDs also lowered itch-scratch response (ISR) to approximately one-third to one-half of the vehicle-treated group. However, these drugs scarcely affected plasma exudation in the conjunctiva. Ketotifen, an H1 histamine receptor antagonist, inhibited both pathophysiological changes (inhibition: 70%-80%). However, this drug was less efficacious than NSAIDs in reducing PGD2 and PGE2 levels. Moreover, topical administration of histamine induced ISR and plasma exudation; in contrast, PGD2 induced ISR exclusively. These results suggest that a part of antigen-induced ISR may be attributable to PGs. However, PGs may not play a key role in plasma exudation; other mediators such as histamine may be involved.


Archive | 1987

3-(1H-tetrazol-5-y1)oxanilic acid and salts thereof and pharmaceutical compositions containing them

Shohei Sawaki; Yasuhiro Ootake; Terumasa Hashimoto; Tooru Abe; Yoshihiro Horio


Japanese Journal of Pharmacology | 1987

Effect of butyl 3-(1H-tetrazol-5-yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue

Terumasa Hashimoto; Shigekatsu Kohno; Katsuya Ohata; Yukiyoshi Yanagihara; Shida T


Archive | 1985

Anti-asthmatic composition and process for preparing the same

Tooru Abe; Yukiyoshi Yanagihara; Takao Shida; Shigekatsu Kohno; Katsuya Ohata; Yoshiaki Ogasawara; Shinji Kageyama; Touru Oguma; Yoshihiro Tsuriya; Toshio Kuroda; Terumasa Hashimoto


Archive | 1987

3-(1H-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound

Shohei Sawaki; Yasuhiro Ootake; Terumasa Hashimoto; Tooru Abe; Yoshihiro Horio


Archive | 1987

3-(1h-tetrazol-5-yl)oxanilsaeure, salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. 3- (1H-tetrazol-5-yl) oxanilsaeure, salts, processes for their preparation and pharmaceutical compositions containing them.

Shohei Sawaki; Yasuhiro Ootake; Terumasa Hashimoto; Tooru Abe; Yoshihiro Horio


Archive | 1987

3-(1H-Tetrazol-5-yl)Oxanilsäure, Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate

Shohei Sawaki; Yasuhiro Ootake; Terumasa Hashimoto; Tooru Abe; Yoshihiro Horio


Archive | 1985

Neue pharmazeutische Verwendung von 5-(3-n-Butyloxalylaminophenyl)-tetrazol Novel pharmaceutical use of 5- (3-n-Butyloxalylaminophenyl) tetrazole

Tooru Abe; Yukiyoshi Yanagihara; Takao Shida; Shigekatsu Kohno; Katsuya Ohata; Yoshiaki Ogasawara; Shinji Kageyama; Touru Oguma; Yoshihiro Tsuriya; Toshio Kuroda; Terumasa Hashimoto


Archive | 1985

Using 5- (3-n-butyloxalylaminophenyl) tetrazole

Tooru Abe; Yukiyoshi Yanagihara; Takao Shida; Shigekatsu Kohno; Katsuya Ohata; Yoshiaki Ogasawara; Shinji Kageyama; Touru Oguma; Yoshihiro Tsuriya; Toshio Kuroda; Terumasa Hashimoto


Archive | 1985

Verwendung von 5-(3-n-butyloxalylaminophenyl)-tetrazol The use of 5- (3-n-butyloxalylaminophenyl) tetrazole

Tooru Abe; Yukiyoshi Yanagihara; Takao Shida; Shigekatsu Kohno; Katsuya Ohata; Yoshiaki Ogasawara; Shinji Kageyama; Touru Oguma; Yoshihiro Tsuriya; Toshio Kuroda; Terumasa Hashimoto

Collaboration


Dive into the Terumasa Hashimoto's collaboration.

Top Co-Authors

Avatar

Shigekatsu Kohno

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Katsuya Ohata

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshio Kuroda

National Institute of Radiological Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shida T

University of Manitoba

View shared research outputs
Researchain Logo
Decentralizing Knowledge